Clinical Trial Update: Clinical Trial of Combination Chemotherapy With Aflibercept in Patients With Advanced Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for combination chemotherapy with aflibercept in advanced/metastatic colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Zaltrap (ramucirumab)

Snippet

Sponsor: Hellenic Cooperative Oncology Group | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: COMPLETED